June 12, 2020 / 8:43 PM / 23 days ago

BRIEF-Concert Pharmaceuticals Releases Additional Data From Phase 2 Clinical Trial Of CTP-543 In Alopecia Areata

June 12 (Reuters) - Concert Pharmaceuticals Inc:

* CONCERT PHARMACEUTICALS RELEASES ADDITIONAL DATA FROM PHASE 2 CLINICAL TRIAL OF CTP-543 IN ALOPECIA AREATA

* CONCERT PHARMACEUTICALS INC - CTP-543 EXPECTED TO ADVANCE INTO PHASE 3 EVALUATION IN Q4 OF 2020

* CONCERT PHARMACEUTICALS INC - ANALYSES SHOW STATISTICALLY SIGNIFICANT DIFFERENCES FROM PLACEBO FOR 8 MG AND 12 MG TWICE-DAILY COHORTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below